Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Reis

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 23, 2015
The Loss of p16 Expression Worsens the Prognosis of OSCCMario Pérez-Sayáns, José M Suárez-Peñaranda, Marí E Padín-Iruegas, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate CancerMiguel Reis Ferreira, Atia Khan, Karen Thomas, et al.
Oral Diseases|August 2, 2021
Clinical outcomes in relapsed oropharyngeal cancer after definitive (chemo) radiotherapyFrancesca De Felice, Thomas Bird, Andriana Michaelidou, et al.
Cancer Communications (London, England)|July 6, 2024
Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosisAnjali Chander, Jacopo Iacovacci, Aize Pellon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2023
Protocol letter: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study (InGReS) - A Phase 1 multicentre feasibility studyDelali Adjogatse, Andriana Michaelidou, Beatriz Sanchez Nieto, et al.
Clinical and Translational Radiation Oncology|October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentationJulia Murray, Clare Cruickshank, Thomas Bird, et al.
Ebiomedicine|July 19, 2024
Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patientsJacopo Iacovacci, Mara Serena Serafini, Barbara Avuzzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2021
TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapyKhrishanthne Sambasivan, Isabel Sassoon, Selvam Thavaraj, et al.
Cancers|April 3, 2021
Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort StudyIfigenia Vasiliadou, Omar Breik, Holly Baker, et al.
BMJ Open Sport & Exercise Medicine|April 6, 2023
Sport and exercise medicine around the world: global challenges for a unique healthcare disciplineJustin Carrard, Ana Morais Azevedo, Boris Gojanovic, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 23, 2015
The Loss of p16 Expression Worsens the Prognosis of OSCCMario Pérez-Sayáns, José M Suárez-Peñaranda, Marí E Padín-Iruegas, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate CancerMiguel Reis Ferreira, Atia Khan, Karen Thomas, et al.
Oral Diseases|August 2, 2021
Clinical outcomes in relapsed oropharyngeal cancer after definitive (chemo) radiotherapyFrancesca De Felice, Thomas Bird, Andriana Michaelidou, et al.
Cancer Communications (London, England)|July 6, 2024
Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosisAnjali Chander, Jacopo Iacovacci, Aize Pellon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2023
Protocol letter: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study (InGReS) - A Phase 1 multicentre feasibility studyDelali Adjogatse, Andriana Michaelidou, Beatriz Sanchez Nieto, et al.
Clinical and Translational Radiation Oncology|October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentationJulia Murray, Clare Cruickshank, Thomas Bird, et al.
Ebiomedicine|July 19, 2024
Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patientsJacopo Iacovacci, Mara Serena Serafini, Barbara Avuzzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2021
TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapyKhrishanthne Sambasivan, Isabel Sassoon, Selvam Thavaraj, et al.
Cancers|April 3, 2021
Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort StudyIfigenia Vasiliadou, Omar Breik, Holly Baker, et al.
BMJ Open Sport & Exercise Medicine|April 6, 2023
Sport and exercise medicine around the world: global challenges for a unique healthcare disciplineJustin Carrard, Ana Morais Azevedo, Boris Gojanovic, et al.
Pageof 4